Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Healthcare creating more opportunities for tech investors, says Harris Financial's Jamie Cox
02:48pm, Friday, 21'st Jul 2023
Jamie Cox, Harris Financial Group managing partner, joins 'The Exchange' to discuss investment opportunities in medical devices, the intersection of healthcare and technology, and top picks in the med
These 13 S&P 500 stocks stand out for expected growth through 2025
10:42am, Thursday, 20'th Jul 2023
As the 2023 stock-market rally continues, this is a good time to look further ahead to see which companies are expected to show the highest growth rates through 2025.
Here is Why Growth Investors Should Buy DexCom (DXCM) Now
02:09pm, Friday, 14'th Jul 2023
DexCom (DXCM) could produce exceptional returns because of its solid growth attributes.
DexCom (DXCM) Stock Hits 52-Week High: More Room to Grow?
09:39am, Friday, 14'th Jul 2023
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
2 Growth Stocks That Could Double in 5 Years
10:15am, Friday, 07'th Jul 2023
DexCom is making continuous glucose monitoring technology more widespread. Etsy is highly successful in its small corner of the large e-commerce industry.
DexCom's (DXCM) G7 CGM System Gets Nod From Health Canada
11:32am, Wednesday, 05'th Jul 2023
DexCom's (DXCM) G7 CGM System's latest approval by Health Canada is expected to combine simplicity and power, thereby providing a better way to manage diabetes.
Looking for a Growth Stock? 3 Reasons Why DexCom (DXCM) is a Solid Choice
02:21pm, Wednesday, 28'th Jun 2023
DexCom (DXCM) could produce exceptional returns because of its solid growth attributes.
Dexcom (DXCM) to Launch New Product in 2024, Ups Long-Term View
09:48am, Tuesday, 27'th Jun 2023
Dexcom (DXCM) announces encouraging developments in 2024, including faster coverage for its products by private payers and new product launch for diabetic patients not on insulin.
Dexcom, A Top 2% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market
08:15pm, Friday, 23'rd Jun 2023
Dexcom's revenue could reach $5 billion in 2025, the company said Friday as it announced a new CGM device. Dexcom stock could soar again.
3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio
06:35am, Thursday, 22'nd Jun 2023
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
10:26am, Wednesday, 21'st Jun 2023
You generally associate Super Bowl commercials with products made by PepsiCo Inc. NYSE: PEP or the Coca-Cola Co. NYSE: KO, but earlier this year, glucose-monitoring geat maker DexCom Inc. NASDAQ: DXCM
Dow Up 428 Points As Stocks Hits 2023 Highs; Chipotle, Dexcom, Hyatt Near Buy Points
05:15pm, Thursday, 15'th Jun 2023
The Dow Jones Industrial Average rallied 428 points Thursday, hitting a 2023 high. Chipotle is one of the stock market leaders to watch.
Frank Sands' Top 1st-Quarter Buys
03:57pm, Tuesday, 06'th Jun 2023
Sands Capital Management recently disclosed its 13F portfolio updates for the first quarter of 2023, which ended on March 31.
Have $1,500? 2 Top Growth Stocks to Buy and Hold for the Long Haul
05:30am, Tuesday, 06'th Jun 2023
The gig economy and diabetes care each represent rapidly-expanding total addressable markets. Fiverr isn't yet profitable, but its bottom line is improving as it grows its revenue and take rate.
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
07:45am, Saturday, 03'rd Jun 2023
Vertex Pharmaceuticals' main franchise has no competition, and it boasts several promising programs. DexCom's opportunities in the continuous glucose monitoring market make it an attractive long-term
